CD14 and metabolic syndrome: In concurrence with other groups that have reported an increase in adipose tissue macrophages [42, 43], in this study, we observed an increase in the percentage of CD14+CD163+ monocyte/macrophage subset in the CD45+ SVF population with the progression of MetS.